The general public did not know much about mRNA vaccines a few months ago; now biotech firms like Moderna, BioNTech or CureVac have almost become household brand-names! We spoke this month with Sander Slootweg, Founder and Managing Partner of Forbion – one of the leading biotech investors in Europe. He told us about the incredible…
This month, IPEM had its monthly rendez-vous with Robin Doumar, Managing Partner and Founder of Park Square Capital, one of the largest players in private debt in Europe. We discussed with Robin the state of the private credit market, how the market rebounded, the opportunities he sees in Europe in the coming months and how…
An accelerating ESG imperative for private equity?Recorded on April 23rd, 2021 How the pandemic accelerated the ESG agenda for institutional investors The expected impact of EU ESG disclosure regulations / taxonomy + trends in other jurisdictions (US, UK…) ESG as a value creation tool / how sustainable businesses proved more resilient in this…
Dear IPEM friends, I hope you are doing well and staying positive! We have been in touch with many of you over the last few weeks and felt a real will of our community to reconnect in person after months of travel and conference starvation. The current context is obviously not easy to navigate but…
The Kauffmann Foundation is a US foundation with $2.6bn AUM and over $1bn invested in PE/VC funds. Diane Mulcahy, Private Equity Adviser at the Foundation is a lecturer in the Entrepreneurship Division at Babson College, visiting fellow at the Bruegel Institute, and a bestselling author of the “Gig Economy” (Harper Collins, 2016). In 2012, Diane…